AL-S Pharma Report issue

For profit Phase 2
Founded: Schlieren Austria (2016)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2019
NCT03981536
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AL-S Pharma | AL-S Pharma SA